Revenues from Contracts and Significant Customers - Additional Information (Details) - product |
3 Months Ended | 6 Months Ended | 12 Months Ended | ||
---|---|---|---|---|---|
Jun. 30, 2019 |
Jun. 30, 2018 |
Jun. 30, 2019 |
Jun. 30, 2018 |
Dec. 31, 2018 |
|
Number of Products | 7 | ||||
Customer One [Member] | Revenue | Customer Concentration Risk [Member] | |||||
Concentration risk, percentage | 53.00% | 27.00% | |||
Customer Two [Member] | Revenue | Customer Concentration Risk [Member] | |||||
Concentration risk, percentage | 11.00% | 16.00% | |||
Customer Three [Member] | Revenue | Customer Concentration Risk [Member] | |||||
Concentration risk, percentage | 12.00% | ||||
3PL Title Model | Revenue | Customer Concentration Risk [Member] | |||||
Concentration risk, percentage | 84.00% | 80.00% | 86.00% | ||
Company's Dermatology Products Customer | Revenue | Customer Concentration Risk [Member] | |||||
Concentration risk, percentage | 77.00% | 80.00% |
X | ||||||||||
- Definition Number of product types. No definition available.
|
X | ||||||||||
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|